Plantar Pain, Balance and Foot Function in Individuals With Diabetes Mellitus
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04444375|
Recruitment Status : Completed
First Posted : June 23, 2020
Last Update Posted : June 30, 2020
|Condition or disease||Intervention/treatment|
|Diabetes Mellitus||Diagnostic Test: balance test|
|Study Type :||Observational|
|Actual Enrollment :||54 participants|
|Official Title:||Plantar Pain, Balance and Foot Function in Individuals With Diabetes Mellitus|
|Actual Study Start Date :||December 1, 2017|
|Actual Primary Completion Date :||May 30, 2018|
|Actual Study Completion Date :||May 30, 2018|
obese and non-obese diabetic patients
Diagnostic Test: balance test
- the Portable Computerized Kinesthetic Equilibrium Device (SportKAT 550) [ Time Frame: 6 months ]balance
- Foot Function Index [ Time Frame: 6 months ]Foot Function Index of 23 items, and evaluates the pain, disability and activity limitation. The each of the pain and insufficiency subscales consist of 9 items and the activity limitation subscale includes 5 items. Patients score their foot pain level with Visual Analogue Scale (VAS) in various situations during the last 1 week. To calculate the scores of the index, the score of each item are summed, then divided by possible the maximum score can be obtained from the FFI. Higher scores indicate greater pain, disability and activity limitation level.
- Manchester Foot Pain and Disability Index [ Time Frame: 6 months ]Manchester Foot Pain and Disability Index consists of 4 subsections including 9 questions for inadequacy, 5 questions for pain, 3 questions for concern and 2 questions for difficulty. Each item is scored between 0-2. The total score is calculated by summing the scores from all items. Higher scores indicate worse health situation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04444375
|Isparta, Turkey, 32200|
|Principal Investigator:||Mehmet Duray||Suleyman Demirel University|